Vancomycin

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

45 API Suppliers, 20 USDMF, 16 CEP/COS, 8 JDMF, 2 EU WC, 13 KDMF, 20 NDC API, 23 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

15 Drugs in Development

15 Drugs in Development

FINISHED DOSAGE FORMULATIONS

322 FDF Dossiers, 142 FDA Orange Book, 76 Europe, 27 Canada, 10 Australia, 13 South Africa, 54 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

POWDER;INTRAVENOUS - EQ 1.25GM BASE/VIAL, POWDER;INTRAVENOUS - EQ 1.5GM BASE/VIAL, POWDER;INTRAVENOUS - EQ 1.75GM BASE/VIAL, POWDER;INTRAVENOUS - EQ 250MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, POWDER;INTRAVENOUS - EQ 2GM BASE/VIAL, POWDER;INTRAVENOUS - EQ 750MG BASE/VIAL, POWDER;INTRAVENOUS, ORAL - EQ 10GM BASE/VIAL, POWDER;INTRAVENOUS, ORAL - EQ 1GM BASE/VIAL, POWDER;INTRAVENOUS, ORAL - EQ 500MG BASE/VIAL, POWDER;INTRAVENOUS, ORAL - EQ 5GM BASE/VIAL, CAPSULE;ORAL - EQ 125MG BASE, CAPSULE;ORAL - EQ 250MG BASE

RELATED EXCIPIENT COMPANIES

2 Seqens, 7 DKSH, 1 Faran Shimi Pharmaceutical, 2 Nanjing Well Pharmaceutical, 4 ACG Worldwide, 6 Actylis, 14 BASF, 2 Finar, 2 Gangwal Chemicals, 3 Lonza Capsugel, 2 Nomisma Healthcare, 1 Pluviaendo, 1 Qualicaps, 6 Roquette, 1 Seppic, 1 Valens Pharmachem

EXCIPIENTS BY APPLICATIONS

12 Topical, 9 Coating Systems & Additives, 9 Thickeners and Stabilizers, 8 Parenteral, 8 Empty Capsules, 6 Film Formers & Plasticizers, 6 Fillers, Diluents & Binders, 6 Solubilizers, 5 Controlled & Modified Release, 4 Granulation, 3 Lubricants & Glidants, 3 Coloring Agents, 3 Taste Masking, 1 Surfactant & Foaming Agents, 1 Direct Compression, 1 Emulsifying Agents